Prospective, Randomized, Multicenter Trial of Peroneal Electrical Transcutaneous Neuromodulation vs Solifenacin in Treatment-naïve Patients With Overactive Bladder.

Jan KrhutMichal RejchrtMartin SlovakRoman V DvorakLukas PeterBertil F M BlokPeter Zvara

Published in: The Journal of urology (2022)

Peroneal electrical transcutaneous neuromodulation is a safe and effective method for overactive bladder treatment associated with a significantly lower incidence of treatment-related adverse events compared to solifenacin and a considerably better benefit-risk profile.

Keyphrases

clinical trial
phase iii
randomized controlled trial
risk factors
open label
combination therapy
study protocol
cross sectional
replacement therapy
placebo controlled